Winton Group LTD Horizon Therapeutics Public LTD CO Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $1,187 - $1,388	-12 Reduced 0.46%	2,617 $302,000
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $797,213 - $929,944	-8,275 Reduced 75.89%	2,629 $270,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $66,645 - $70,483	-621 Reduced 5.39%	10,904 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $129,771 - $236,704	-2,080 Reduced 15.29%	11,525 $1.31 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $209,048 - $300,409	3,548 Added 35.28%	13,605 $842,000
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $798,525 - $1.17 Million	10,057 New	10,057 $802,000
Q1 2022 May 11, 2022	SELL	$86.42 - $109.81 $285,531 - $362,812	-3,304 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $116,202 - $141,373	1,179 Added 55.48%	3,304 $356,000
Q3 2021 Oct 28, 2021	BUY	$91.91 - $110.37 $195,308 - $234,536	2,125 New	2,125 $233,000
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $277,089 - $308,190	-3,213 Closed	0 $0
Q1 2021 Jul 21, 2021	BUY	$71.83 - $95.48 $230,789 - $306,777	3,213 New	3,213 $296,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $1.65 Million - $2.08 Million	-24,591 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$55.23 - $79.93 $1.18 Million - $1.71 Million	-21,434 Reduced 46.57%	24,591 $1.91 Million
Q2 2020 Aug 05, 2020	SELL	$30.2 - $56.98 $1.58 Million - $2.99 Million	-52,395 Reduced 53.24%	46,025 $2.56 Million
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $2.27 Million - $3.53 Million	-91,434 Reduced 48.16%	98,420 $2.92 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $3.75 Million - $5.4 Million	147,380 Added 346.99%	189,854 $6.87 Million
Q3 2019 Nov 08, 2019	BUY	$23.0 - $27.97 $976,902 - $1.19 Million	42,474 New	42,474 $1.16 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account